Identifying Targets and Drugs for Rheumatoid Arthritis Stratified Therapy Using Mendelian Randomization and a Pretraining Model
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125686 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yuqing Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430074, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Mendelian Randomization Analysis, Antirheumatic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province, Huazhong Agricultural University Scientific & Technological Self-innovation Foundation, Hubei Provincial Natural Science Foundation and Traditional Chinese Medicine Innovation and Development Joint Foundation of China.
Abstract (Originalsprache)
The prevalence of rheumatoid arthritis (RA) subtypes, including seropositive and seronegative, is influenced by lifestyle factors and exhibits high heterogeneity, resulting in reduced drug efficacy. This study aims to identify cytokines mediating the effects of different lifestyles on RA subtypes and to discover new drugs for personalized treatment. Mendelian randomization revealed that three cytokines (MIP1b, SCGFb, and TRAIL) partially mediated the effects of different lifestyles on RA overall or its subtypes. The pretrained model, i.e., DrugBAN, predicted the probability of 723,000 small molecule drugs binding to these three targets. In molecules with high binding rates, we calculated the structural similarity between known drugs for RA and other drugs to screen for new drugs, followed by molecular docking and molecular dynamics simulations for validation. The results indicate that these targets had promising binding affinity with known drugs and other drugs with high similarity. Our findings may guide therapeutic approaches for heterogeneous RA patients with specific lifestyle habits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430074, China.
ORCID-Profile: Yixuan Sun, Feiyang Xue, Shichao Liu, Xiaohui Niu
Förderung
- Natural Science Foundation of Hubei Province
- Huazhong Agricultural University Scientific & Technological Self-innovation Foundation
- Hubei Provincial Natural Science Foundation and Traditional Chinese Medicine Innovation and Development Joint Foundation of China
- Huazhong Agricultural University Scientific & Technological Self-Innovation Foundation
Zitieren
APA
Yan, Y., Wu, Y., Sun, Y., Wu, T., Zhu, H., Xue, F., Yu, Z., Liu, S., & Niu, X. (2025). Identifying Targets and Drugs for Rheumatoid Arthritis Stratified Therapy Using Mendelian Randomization and a Pretraining Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125686
Vancouver
Yan Y, Wu Y, Sun Y, Wu T, Zhu H, Xue F, et al. Identifying Targets and Drugs for Rheumatoid Arthritis Stratified Therapy Using Mendelian Randomization and a Pretraining Model. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125686
BibTeX
@article{Yan2025,
author = {Yan, Yuqing and Wu, You and Sun, Yixuan and Wu, Tian and Zhu, Haotian and Xue, Feiyang and Yu, Zhanhui and Liu, Shichao and Niu, Xiaohui},
title = {Identifying Targets and Drugs for Rheumatoid Arthritis Stratified Therapy Using Mendelian Randomization and a Pretraining Model},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125686}
}
EUVIMED